Home > Cashflow Statement > ORCHID PHARMA

ORCHID PHARMA
Cash Flow from Investing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Investing Activities ₹-312 Cr₹-31 Cr₹113 Cr₹67 Cr₹167 Cr

What is the latest Cash Flow from Investing Activities ratio of ORCHID PHARMA ?

The latest Cash Flow from Investing Activities ratio of ORCHID PHARMA is ₹-312 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Investing Activities
Mar2024₹-312 Cr
Mar2023₹-31 Cr
Mar2022₹113 Cr
Mar2021₹67 Cr
Mar2020₹167 Cr

How is Cash Flow from Investing Activities of ORCHID PHARMA Trending?

Years Cash Flow from Investing Activities % Change
Mar2024 ₹-312 Cr
Negative
Mar2023 ₹-31 Cr
Negative
Mar2022 ₹113 Cr
68.05
Mar2021 ₹67 Cr
-59.78
Mar2020 ₹167 Cr -

Compare Cash Flow from Investing Activities of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,752.3 Cr 4.2% 2.3% -48.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,219.0 Cr 0.4% 1.7% 2% Stock Analytics
DIVIS LABORATORIES ₹175,227.0 Cr -0.3% -3.8% 35.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,643.0 Cr 3.9% 11.8% 20% Stock Analytics
CIPLA ₹125,541.0 Cr 1.5% 3.8% 2% Stock Analytics
DR REDDYS LABORATORIES ₹106,063.0 Cr -0.5% -0.1% -5.1% Stock Analytics


ORCHID PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

4.2%

2.3%

-48.7%

SENSEX

-1.2%

-3%

-0.2%


You may also like the below Video Courses